FDA advisory panel voted 8-6 to recommend compounding pharmacies access BPC-157, opposing FDA scientists' safety concerns. RFK Jr. supports expansion; Hims & Hers among companies poised to benefit.
July 23, 2026 02:34 PM EDT
FDA adcomm votes in favor of lifting restrictions on popular wellness peptide BPC-157
An FDA advisory committee voted Thursday to recommend expanding access to a popular peptide used by health and wellness enthusiasts for repairing muscles and healing …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
Votes go against agency scientists' recommendation to keep them off the compounding list
An FDA advisory committee voted on Thursday to add the popular peptide BPC-157 to a drug compounding list.
The panel went against the conclusions of the agency’s career scientists, who said there was not enough evidence to support the…
The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.
‘I’m a big fan of peptides; I’ve used them myself and used them with really good effect,’ the Secretary told Joe Rogan in February
The group met on July 24 to vote on whether compounding pharmacies could legally dispense certain peptides.
